Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Status
Not yet recruiting
Trial Recruitment Size
100
Trial Sponsor
Clinical Trial Start Date
August 26, 2020
Primary Completion Date
March 5, 2021
Study Completion Date
March 5, 2021
Clinical Trial Study Type
Interventional
Interventional Trial Purpose
Prevention0
Intervention Type
Biological
Intervention Name
AZD12220
Interventional Trial Phase
Phase 3
Official Name
A Phase III Open-label Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-190
Last Updated
October 1, 2021
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
No article content yet.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
